Atlas Trials

Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer

Clinical trial NCT03638193 · UNKNOWN

Trial details

NCT number
NCT03638193
Sponsor
Shenzhen BinDeBio Ltd.
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2018-07-11
Primary completion
2022-02-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.